Keyphrases
Cyclooxygenase-2
100%
Tumour Necrosis Factor Inhibitor (TNFi)
100%
Ulcerative Colitis
100%
Primary Non-responder
80%
Monocytes
60%
Prostaglandin E2
60%
Cyclooxygenase-2 Expression
60%
Tumor Necrosis Factor-α
40%
Inflammatory State
20%
Intestinal Biopsy
20%
Prostaglandins
20%
Treatment Resistance
20%
Disease Research
20%
Tissue Repair
20%
Downstream Effectors
20%
Patient-derived
20%
NIH Funding
20%
Human Intestinal Epithelial Cells
20%
Clinical Response
20%
Lineage Differentiation
20%
Dual Function
20%
Thromboxane
20%
Lundbeck
20%
Lack of Response
20%
Digestive Diseases
20%
Stem Cell Self-renewal
20%
Induction Therapy
20%
Intestinal Stem Cells
20%
Mini-gut
20%
Downstream Consequences
20%
Novo Nordisk
20%
Differentiation of Self
20%
Inflammation
20%
Mucin
20%
Medicine and Dentistry
Regeneration
100%
Cyclooxygenase 2
100%
Ulcerative Colitis
100%
TNF Inhibitor
100%
Tumor Necrosis Factor
25%
Gut
12%
Tissue Repair
12%
Prostaglandin
12%
Lomustine
12%
Gastrointestinal Disease
12%
Epithelial Cell
12%
Stem Cell Self-Renewal
12%
Intestine Biopsy
12%
Mucin
12%
Thromboxane A2
12%
Organoid
12%
Biochemistry, Genetics and Molecular Biology
TNF Inhibitor
100%
Cyclooxygenase
100%
Tumor Necrosis Factor
25%
Tissue Repair
12%
Prostaglandin
12%
Thromboxane A2
12%
Mucin
12%
Stem Cell Self-Renewal
12%